Li Z - Search Results

1

Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer.

Wesolowski R, Stiff A, Quiroga D, McQuinn C, Li Z, Nitta H, Savardekar H, Benner B, Ramaswamy B, Lustberg M, Layman RM, Macrae E, Kassem M, Williams N, Sardesai S, VanDeusen J, Stover D, Cherian M, Mace TA, Yu L, Duggan M, Carson WE 3rd. Wesolowski R, et al. Among authors: li z. BMC Cancer. 2020 May 19;20(1):445. doi: 10.1186/s12885-020-06949-4. BMC Cancer. 2020. PMID: 32429929 Free PMC article.

2

HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer.

Hou Y, Nitta H, Li Z. Hou Y, et al. Among authors: li z. Am J Clin Pathol. 2017 Jan 1;147(1):89-95. doi: 10.1093/ajcp/aqw211. Am J Clin Pathol. 2017. PMID: 28110280

3

HER2 intratumoral heterogeneity is independently associated with incomplete response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma.

Hou Y, Nitta H, Wei L, Banks PM, Portier B, Parwani AV, Li Z. Hou Y, et al. Among authors: li z. Breast Cancer Res Treat. 2017 Nov;166(2):447-457. doi: 10.1007/s10549-017-4453-8. Epub 2017 Aug 10. Breast Cancer Res Treat. 2017. PMID: 28799059

4

Evaluation of Immune Reaction and PD-L1 Expression Using Multiplex Immunohistochemistry in HER2-Positive Breast Cancer: The Association With Response to Anti-HER2 Neoadjuvant Therapy.

Hou Y, Nitta H, Wei L, Banks PM, Parwani AV, Li Z. Hou Y, et al. Among authors: li z. Clin Breast Cancer. 2018 Apr;18(2):e237-e244. doi: 10.1016/j.clbc.2017.11.001. Epub 2017 Nov 9. Clin Breast Cancer. 2018. PMID: 29198959 Free PMC article.

5

PD-L1 expression and CD8-positive T cells are associated with favorable survival in HER2-positive invasive breast cancer.

Hou Y, Nitta H, Wei L, Banks PM, Lustberg M, Wesolowski R, Ramaswamy B, Parwani AV, Li Z. Hou Y, et al. Among authors: li z. Breast J. 2018 Nov;24(6):911-919. doi: 10.1111/tbj.13112. Epub 2018 Sep 19. Breast J. 2018. PMID: 30230111 Free PMC article.

6

Identification of HER2 Immunohistochemistry-Negative, FISH-Amplified Breast Cancers and Their Response to Anti-HER2 Neoadjuvant Chemotherapy.

Gibbons-Fideler IS, Nitta H, Murillo A, Tozbikian G, Banks P, Parwani AV, Li Z. Gibbons-Fideler IS, et al. Among authors: li z. Am J Clin Pathol. 2019 Jan 7;151(2):176-184. doi: 10.1093/ajcp/aqy136. Am J Clin Pathol. 2019. PMID: 30339245

7

PD-L1 and CD8 are associated with deficient mismatch repair status in triple-negative and HER2-positive breast cancers.

Hou Y, Nitta H, Parwani AV, Li Z. Hou Y, et al. Among authors: li z. Hum Pathol. 2019 Apr;86:108-114. doi: 10.1016/j.humpath.2018.12.007. Epub 2019 Jan 8. Hum Pathol. 2019. PMID: 30633926

8

Clinicopathologic characteristics, tumor infiltrating lymphocytes and programed cell death ligand-1 expression in 162 endometrial carcinomas with deficient mismatch repair function.

Chavez JA, Wei L, Suarez AA, Parwani AV, Li Z. Chavez JA, et al. Among authors: li z. Int J Gynecol Cancer. 2019 Jan;29(1):113-118. doi: 10.1136/ijgc-2018-000042. Int J Gynecol Cancer. 2019. PMID: 30640692 Free PMC article.

9

Programmed cell death ligand 1 expression in cytologic and surgical non-small cell lung carcinoma specimens from a single institution: Association with clinicopathologic features and molecular alterations.

Mei P, Shilo K, Wei L, Shen R, Tonkovich D, Li Z. Mei P, et al. Among authors: li z. Cancer Cytopathol. 2019 Jul;127(7):447-457. doi: 10.1002/cncy.22140. Epub 2019 Apr 26. Cancer Cytopathol. 2019. PMID: 31025831 Free PMC article.

10

The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative Chemotherapy.

Waks AG, Stover DG, Guerriero JL, Dillon D, Barry WT, Gjini E, Hartl C, Lo W, Savoie J, Brock J, Wesolowski R, Li Z, Damicis A, Philips AV, Wu Y, Yang F, Sullivan A, Danaher P, Brauer HA, Osmani W, Lipschitz M, Hoadley KA, Goldberg M, Perou CM, Rodig S, Winer EP, Krop IE, Mittendorf EA, Tolaney SM. Waks AG, et al. Among authors: li z. Clin Cancer Res. 2019 Aug 1;25(15):4644-4655. doi: 10.1158/1078-0432.CCR-19-0173. Epub 2019 May 6. Clin Cancer Res. 2019. PMID: 31061067 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104,284 results

Search Page